The Prescription for Resilience

Practical Policy Solutions for Securing our Pharmaceutical Supply Chain
Hosted by Angels for Change
Date: Thursday, November 13, 2025
Location: Russell Senate Building, Kennedy Caucus Room | Washington, D.C.

2 Constitution Ave. NW, Washington, DC 20001, USA
Time: 9:30 AM – 4:00 PM EST

America’s drug shortage crisis demands urgent, united action. Join Angels for Change for SummitONE PolicyLAB: The Prescription for Resilience, a single-day summit bringing together healthcare leaders, policymakers, supply chain innovators, and advocates to develop actionable policy solutions ensuring access to essential medications.

This invite-only event spotlights real-world policy interventions to build a resilient pharmaceutical supply chain for the American people. Hear directly from those leading the change and engage in an interactive multi-stakeholder roundtable.

9:30 - 9:45 AM
REGISTRATION & BREAKFAST

8:45 - 9:50 AM
OPENING | WELCOME

Laura Bray, Founder, Angels for Change

PANEL 1: Building a Resilient Future: The Prescription for Resilience 9:50 AM – 10:35 AM | Live Panel 10:35 – 10:40 PM | Panel Q&A 10:40 – 11:10 PM | Facilitated Stakeholder Breakout

Panel Description:
A Broken Market needs supply and demand side solutions. Examine how long-term sustainability and resilience needs targeted Medicare reimbursement reform especially for the generic sterile injectable (GSI) market. Discussion of third-party resiliency programs, CMS certification, out come measures, and hospital reimbursement alignment.

Key Topics:

  • Economic root causes of shortages

  • The race to the bottom for generic medicines

  • Structuring reimbursement to reward resiliency

  • Role of GPOs, distributors, and CMS in implementation

Moderator: Allan Coukell, Chief Government Affairs and Public Policy Officer, CivicaRx

PANEL 2: Shelves are Empty: Open the Door to Alternatives 11:10 AM – 11:40 PM | Live Panel 11:40 – 11:45 PM | Panel Q&A 11:45 – 12:15 PM | Facilitated Stakeholder Breakout

Panel Description:
When Treatment Runs Short, Coverage Must Step Up. Explore how federal policy can require private payers to cover clinically appropriate alternatives when a drug is in shortage—without burdensome prior authorizations.

Key Topics:

  • Patient access barriers during shortages

  • Insurer roles in shortage mitigation

  • Legislative mechanisms for automatic coverage

12:15 - 1:10 PM
LUNCH | NETWORKING

Panel 3: Building our Buffer - Ensuring Supply During Shortage 1:15 PM – 1:50 PM | Live Panel 1:50 – 2:00 PM | Panel Q&A 2:00 – 2:30 PM | Facilitated Stakeholder Breakout

Panel Description:
When the Supply Chain Breaks: Who's Holding the Buffer? How should we respond? How do we ensure its enough for the American people? This panel will address how strategic policies can help our nation respond to drug shortages. Ensuring the supply chain bends but doesn’t break. We will discuss how to prevent artificial shortages caused by hoarding, while ensuring flexible distribution of essential medicines—especially during public health emergencies.

Key Topics:

  • Creating and sustaining buffer stock

  • Preventing demand spikes and demand-based shortages

  • Examine allocation process

  • Emergency preparedness and real-time distribution coordination

  • Public-private partnerships in building proactive supply readiness and response

Moderator: Chandresh Harjivan, Former Special Assistant to the President, Preparedness and Response

Panel 4: Fortifying Access  – Onshoring, API, and the Role of 503B in Resilience 2:35 PM – 3:10 PM | Live Panel 3:10 – 3:20 PM | Panel Q&A 3:20 – 3:50 PM | Facilitated Stakeholder Breakout

Panel Description:
This panel will explore how strengthening domestic manufacturing capacity —from API production and essential medicine production to expanding the role of 503B outsourcing facilities can enhance the resiliency of the drug supply chain. Panelists will discuss policy, incentives, and strategic investments to support U.S.-based manufacturing, ensure economic sustainability, and maintain a state of readiness to build resilient domestic capacity and respond to shortages of essential medicines.

Key Topics:

  • How to be Ready

  • Incentives for API production and generic manufacturing

  • Coordination between supply chain and health systems during shortages

  • Federal investments in onshoring critical supply chain components.

Moderator: James Coburn, Portfolio Lead, ARPA-H

3:40 - 3:45 PM
CLOSING | NEXT STEPS

Laura Bray, Founder, Angels for Change
Summary and Next Steps

Save the Date for ELEVATE SummitONE 2026
7.28.26-7.29.26 New York, NY hosted by Pfizer

Print Agenda